Dermatology medical coding is a precise discipline that directly impacts a practice’s financial health. Every skin examination, biopsy, excision, and repair requires a specific Current Procedural Terminology (CPT) code that tells the payer exactly what service you performed. Choosing the wrong code leads to claim denials, delayed payments, and compliance risk. This comprehensive guide walks you through the essential dermatology CPT codes, from evaluation and management to complex surgical repairs. You will gain the knowledge to code with confidence and accuracy.
The Foundation of Dermatology Coding
Before exploring specific procedure codes, you must understand the core principles that govern all dermatology billing. CPT codes are the universal language of medical services, maintained by the American Medical Association. They translate your clinical work into a numeric format that payers can process. In dermatology, these codes span from routine office visits to highly complex micrographic surgeries.
Understanding CPT Code Categories
CPT codes divide into three main categories, and dermatology uses all of them. Category I codes are the standard codes for widely performed procedures, and they represent the vast majority of dermatology billing. Category II codes are optional tracking codes used for performance measurement, such as documenting a biopsy pathology follow-up. Category III codes are temporary codes for emerging technologies and procedures, like certain laser therapies that have not yet achieved widespread adoption. A proficient coder knows which category to pull from and never submits a Category II code as a primary service code.
The Role of Accurate Diagnosis Coding
A CPT code describes what you did, but the ICD-10-CM diagnosis code describes why you did it. Medical necessity is the bridge between the two. A payer will not reimburse a complex closure CPT code if the diagnosis is a benign cosmetic lesion without medical indication. Your documentation must tell a clear clinical story. The lesion’s morphology, location, symptomatic nature, and suspicion for malignancy all justify the procedure. Pairing the correct ICD-10 code, such as L82.1 for a seborrheic keratosis or C44.91 for a basal cell carcinoma, with the appropriate CPT code creates an unbreakable claim.
Evaluation and Management (E/M) Codes in Dermatology
Every patient encounter begins with an Evaluation and Management service. The 2021 E/M guideline changes significantly simplified office visit coding, and dermatology practices must fully adopt this modern framework. Using outdated history and physical exam counting rules will lead to undercoding and lost revenue.
Selecting the Correct E/M Level
Medical decision making (MDM) or total time on the date of the encounter now defines the E/M level for established and new patients. You no longer need to document a specific number of bullet points in the history and physical exam. The MDM table has three core elements: the number and complexity of problems addressed, the amount and complexity of data reviewed and analyzed, and the risk of complications and patient management. A self-limited minor problem like a wart leads to straightforward MDM. A suspicious pigmented lesion requiring biopsy with a review of pathology from a prior visit is moderate MDM. Mapping your clinical thought process to these MDM levels ensures you capture the full value of your cognitive work.
Key Dermatology E/M CPT Codes
The most frequently used E/M codes for dermatology are straightforward. For a new patient, 99202 represents a straightforward visit, 99203 a low level, 99204 a moderate level, and 99205 a high level of medical decision making. For an established patient, the corresponding codes are 99212, 99213, 99214, and 99215. A focused skin check for a patient with a history of actinic keratosis who has a new, single concerning lesion, where you perform a biopsy, typically maps to 99213 or 99214 depending on the complexity of data review, such as comparing dermoscopic findings to a prior photo. Documenting your total time spent on the visit date when counseling dominates is an equally valid and often simpler method.
Biopsy CPT Codes: The Diagnostic Core
A skin biopsy is the most fundamental dermatology procedure. The CPT code for a biopsy is independent of the closure method. Many coders and clinicians incorrectly bill an excision code when they intended a biopsy. The definitive difference is intent. A biopsy removes a piece of a lesion for diagnostic tissue. An excision removes the entire lesion with curative intent.
Shave, Punch, and Incisional Biopsy Codes
The three primary biopsy techniques have distinct codes. A shave biopsy (codes 11102, 11103, 11104) uses a flexible blade to horizontally remove a sample of epidermal and dermal tissue. A punch biopsy (codes 11104, 11105, 11106) uses a circular blade to extract a cylindrical core of full-thickness skin. An incisional biopsy (also captured by 11104-11106) uses a scalpel to remove a wedge of tissue.
Codes 11102, 11104, and 11105 are for the first biopsy, while 11103, 11106, and 11107 are add-on codes for each additional biopsy taken during the same session. You bill one primary code, and each additional biopsy, regardless of the technique, is an add-on line. Payers bundle payment for multiple biopsies, but you must accurately list them all to document the full extent of the service.
The Tangential Biopsy vs. Shave Removal Distinction
This is a common coding pitfall. A tangential biopsy (shave biopsy) takes a sample for pathologic examination. A shave removal, reported with codes 11300-11313, is a full-thickness removal of an entire lesion, typically using the same tangential technique. The clinical record must clearly state “biopsy” when you bill a 11102 code. The pathologist’s report should confirm that the specimen was submitted for diagnostic examination. If you remove the entire visible lesion in one piece with a shave technique, even if you suspect a malignancy, and you are not intentionally leaving residual disease, you are performing a shave removal, not a biopsy. Your choice of code hinges on the documented clinical intent before the blade touches the skin.
Benign and Malignant Excision Codes
When the procedure’s intent is the complete removal of a lesion, you select an excision code. The code category depends on the pathology or, for initial coding, the strongest clinical suspicion. Excision codes are organized by benign versus malignant and then by anatomical location and excised diameter. The excised diameter includes both the lesion and the narrowest margin required to completely remove it.
Coding Excision by Lesion Type and Location
Benign excisions fall under codes 11400-11471. You select the code based on the body area (trunk, scalp, face, etc.) and the greatest clinical diameter of the excised lesion plus the margin. Malignant excisions, including basal cell carcinoma, squamous cell carcinoma, and melanoma, fall under codes 11600-11646. Malignant excision codes are similarly stratified by location and size but carry higher relative value units due to the typical need for wider margins and more complex closure.
Documenting the exact pre-operative size measurement is non-negotiable. A note stating “2 cm lesion excised” is ambiguous. You must document “a lesion measuring 1.2 cm was excised with 0.4 cm margins, resulting in an excised diameter of 2.0 cm.” This precision directly translates to a specific code. A 2.0 cm malignant excision on the arm is 11603, while a 2.1 cm excision is 11604.
Intermediate and Complex Repair Codes
The closure of a surgical wound is often a separately billable service, but only when it requires significant skill and time beyond simple closure. Simple repairs (single-layer closure) are bundled into the excision code. You can only bill a repair code separately when an intermediate or complex layered closure is medically necessary.
Defining Intermediate and Complex Closures
An intermediate repair (codes 12031-12057) involves a layered closure of one or more deeper layers of subcutaneous tissue and superficial fascia in addition to the skin. It is used for deeper wounds that require reinforcement to reduce wound tension. A complex repair (codes 13100-13153) is more than just a layered closure. It requires significant scar revision, extensive undermining, stenting, or retention sutures. A complex repair is a reconstructive procedure, not a routine wound closure.
The repair codes are additive. You code the primary repair size and then add codes for additional repairs in the same classification and anatomical group. The size is the total length of the wound closed, not the lesion diameter. This is a critical measurement shift. An excision code is based on the pre-operative excised diameter. The repair code is based on the final post-excision wound length, which will be significantly longer due to the elliptical shape.
Grafts, Flaps, and Advanced Reconstruction
When a wound is too large or complex for a layered linear closure, dermatologic surgeons utilize grafts and flaps. These advanced reconstruction codes are a significant portion of a surgical dermatologist’s revenue stream. A split-thickness skin graft (15100-15121) and a full-thickness skin graft (15240-15261) have codes based on the recipient site size.
Adjacent tissue transfer or rearrangement procedures, commonly called flaps (codes 14000-14352), are used to close defects by shifting nearby tissue. The code selection is based on the anatomical site and the size of the primary defect, not the secondary defect or the flap itself. For a Mohs surgery defect on the nasal ala measuring 1.5 cm, the adjacent tissue transfer code is 14060. The operative report must clearly diagram or describe the defect and the flap design to justify the code.
Mohs Micrographic Surgery Codes
Mohs surgery is a unique dermatologic procedure with its own dedicated CPT code set. It combines surgical removal with immediate microscopic margin analysis by the surgeon. The codes reflect the dual role of surgeon and pathologist. You bill separate codes for the surgical layers removed and for the pathologic interpretation.
Mohs Surgery Staging and Pathology
The Mohs surgeon removes tissue in sequential stages, mapping each layer. CPT codes 17311-17315 describe the surgical procedure of tissue removal. Code 17311 is for the first stage of Mohs on the head, neck, hands, feet, or genitalia. 17312 is for each additional stage after the first. Codes 17313-17315 follow the same logic for trunk, arms, and legs.
The pathology component is billed with 88331 for the first tissue block and 88332 for each additional block from the same specimen. A complex tumor requiring three Mohs stages on the nose, with two blocks prepared in the first stage and three in the second, generates a specific set of codes. The surgical portion is 17311 and 17312 x2. The pathology portion is 88331, 88332 x1 (for the first stage), and 88331, 88332 x2 (for the second stage). The modifier 59 or XS may be necessary to distinguish the separate stages if billed on the same service date.
The Role of the Mohs Surgeon as Pathologist
This is a contentious audit area. For the Mohs surgeon to bill the pathology codes (88331-88332), they must personally examine the microscope slides and prepare a written pathology report for each stage. If the surgeon sends the frozen sections to an external pathologist for interpretation, the surgeon cannot bill the 88331-88332 codes. The external pathologist would bill for the professional component. The surgeon’s documentation must include a specific note describing the microscopic findings, the interpretation, and the mapping, proving they performed the pathology work.
Destructive and Benign Lesion Removal Methods
Not all lesions require a scalpel. Dermatologists treat many conditions with destructive methods. These procedures have their own code families. Selecting the correct code requires understanding the method (laser, cryosurgery, electrosurgery) and the lesion type.
Cryosurgery, Electrosurgery, and Laser Codes
Destruction of benign, premalignant, or malignant lesions uses codes based on the lesion type. Destruction of actinic keratoses is CPT 17000, 17003, or 17004, depending on the number of lesions treated. Destruction of benign lesions, like warts or molluscum contagiosum, is reported with 17110 or 17111. Destruction of malignant lesions, such as a basal cell carcinoma treated with electrodesiccation and curettage, is 17260-17286, with code choice dependent on the lesion size and location.
The method of destruction must be documented. Laser destruction of condylomata (warts) is a specific procedure with its own coding considerations. Coverage for laser procedures, especially for cosmetic or non-essential indications, is highly payer-specific. An Advance Beneficiary Notice of Noncoverage is mandatory when performing laser destruction for a condition that the payer may deem cosmetic, like facial telangiectasias.
Premalignant Lesion Destruction
Actinic keratoses (AKs) represent a massive volume of dermatology billing. The code 17000 is for the destruction of the first AK. Codes 17003 and 17004 are add-on codes for the destruction of two to fourteen additional AKs and fifteen or more additional AKs, respectively. The documentation must state the total number of lesions destroyed. A note saying “multiple AKs treated with liquid nitrogen” is insufficient. You must record “15 AKs were destroyed on the face and scalp,” which directly supports code 17000 and 17004. You should not use these codes for the destruction of seborrheic keratoses, which are benign lesions and have a separate code (17110).
Phototherapy and Photodynamic Therapy Codes
Light-based therapies are a cornerstone of modern dermatology. The coding for these services separates the actual light application from the photosensitizing drug. Phototherapy is for treatment of conditions like psoriasis and vitiligo, while Photodynamic Therapy (PDT) combines a topical drug with a specific light source to treat actinic keratoses and superficial skin cancers.
Billing for UVB, PUVA, and PDT Services
Ultraviolet B (UVB) therapy is billed with 96900 for a single treatment. Ultraviolet A (UVA) therapy with psoralen (PUVA) has codes for both the light application and the drug. Topical chemotherapy application like calcipotriene before phototherapy is a separately reportable service in some contexts. PDT billing has two parts. Code 96567 is for the application of the photosensitizing drug, typically aminolevulinic acid (ALA), followed by a period of incubation. The light activation is a separate procedure, typically reported with 96573 when using a blue light source. A single PDT session often generates a claim with two lines: 96567-59 and 96573. Payer policies, especially Medicare, have strict frequency limits on PDT, so verifying medical necessity documentation is essential.
Key Dermatology Modifiers
Modifiers clarify a performed procedure without changing its fundamental definition. In dermatology, several modifiers are used daily to prevent claim bundling denials. Modifier 25 and the various site-specific modifiers are the most critical to master.
Modifier 25: The Essential E/M Modifier
Modifier 25 signals that a separately identifiable Evaluation and Management service occurred on the same day as a minor procedure. The E/M service must be above and beyond the usual pre- and post-operative work of the procedure. If a patient comes in for a single warty lesion, the E/M is bundled into the destruction. However, if a patient presents for a total body skin exam, you discover a concerning mole that requires a biopsy, and you also manage the patient’s chronic eczema, you can bill an E/M with modifier 25 appended. The documentation must clearly separate the E/M elements from the biopsy procedure note. The chief complaint, history, exam, and medical decision making for the eczema and skin exam are the distinct service; the biopsy is the planned procedure.
Anatomical Modifiers and the NCCI
The National Correct Coding Initiative (NCCI) bundles many procedure pairs. When you perform two distinct procedures that NCCI bundles but are in separate anatomical locations, you use anatomical modifiers. The most common are E1-E4 for eyelids, FA for the left hand, and T for the left foot. For standard body areas, the LT (left side) and RT (right side) modifiers are insufficient for some payer-specific policies.
The modifier 59 (Distinct Procedural Service) is the modifier of last resort. You use it when no other descriptive modifier fits and you can prove the two procedures were truly separate, such as a different session, different site, or different lesion. Payers heavily scrutinize the overuse of modifier 59. A better approach is using the more specific X-modifiers like XS (Separate Structure) when you biopsy a lesion on the nose and destroy an actinic keratosis on the cheek. This tells a clear, audit-proof story of separate sites.
Pathology and Laboratory Integration
The dermatology revenue cycle extends beyond the clinic walls. When you send a biopsy specimen to a pathologist, the pathology interpretation is a critical component of care. How this service is billed depends on the contractual relationship between your practice and the laboratory.
Billing for External vs. In-House Pathology
If your practice operates a CLIA-certified histology laboratory and a dermatopathologist interprets the slide, you bill the global pathology service. This typically uses CPT codes 88305 for a standard skin biopsy. If you send the tissue to an independent reference laboratory, you generally should not mark up or bill for their service. The laboratory bills the payer and patient directly. An exception is the “purchased service” model, where your practice purchases the technical component from the lab and bills the global service. This arrangement requires a strict contractual agreement and full transparency. A medical directorship or anti-markup rule violation can occur if not structured correctly. The safest and cleanest path is transparent referral to a trusted dermatopathology partner.
Conclusion
Mastering dermatology CPT codes is a continuous investment in your practice’s precision and profitability. It requires an unbreakable link between clinical documentation and code selection, a clear understanding of the intent behind biopsies versus excisions, and the disciplined use of modifiers to tell the full surgical story. By treating coding as a clinical and financial bridge, you protect your practice from audits and ensure you receive the full, legitimate reimbursement for the expert care you deliver. A well-coded claim is the final, essential step in every successful patient encounter.
Frequently Asked Questions
Q: Can I bill an E/M service on the same day as a routine full-body skin exam if I find a malignant lesion and excise it?
A: Yes, but only if the E/M service for the full-body skin exam is a separately identifiable service from the decision to excise the already-identified lesion. If the patient’s only complaint was the single lesion you excised, you cannot bill a separate E/M. The documentation must clearly detail the distinct, medically necessary work of the comprehensive exam.
Q: What is the primary difference between a complex repair and an adjacent tissue transfer?
A: A complex repair is a layered closure that brings wound edges together directly, even with extensive undermining. An adjacent tissue transfer (flap) moves adjacent tissue into the defect through a defined vascular pedicle or geometric rearrangement. If you cut a flap to move tissue, you are not performing a repair. The operative report must describe the flap design.
Q: How do I code an excision of a benign lesion that the pathology report later confirms is a basal cell carcinoma?
A: You code based on the pathology result, not the pre-operative suspicion. If you had a reasonable suspicion it was benign but the pathology returns malignant, you must code the malignant excision CPT code (11600-11646) with the malignant ICD-10 code.
Additional Resource
For the most definitive coding guidance, always refer to the source material from the professional society most aligned with dermatology billing compliance.
- American Academy of Dermatology Association Coding Resource: aad.org/member/practice/coding
